CHD1 is a synthetic lethal target in phosphatase and tensin homologue (PTEN)-deficient cancers.84 Although it has been acknowledged as an attractive pharmacological target, no inhibitors or antagonists of CHD1 were reported until 2024. Here, CHD1 is linked to cancer.